RBC Bioscience Corporation (6848.TWO)

TWD 17.7

(-2.21%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 172.46 Million 173.89 Million 251.18 Million 575.16 Million 161.67 Million
Cost of Revenue 99.57 Million 100.88 Million 134.11 Million 274.83 Million 94.78 Million
Gross Profit 72.89 Million 73 Million 117.07 Million 300.32 Million 66.89 Million
Operating Expenses 58.35 Million 65.35 Million 68.83 Million 111.94 Million 19.51 Million
Selling, General and Administrative Expenses 47.51 Million 49.61 Million 52.44 Million 89.7 Million 38.58 Million
Research and Development Expenses 10.83 Million 15.74 Million 16.39 Million 22.23 Million 8.79 Million
Other Expenses - 4.57 Million -5.96 Million -9.49 Million 19.51 Million
Cost and Expenses 157.92 Million 166.23 Million 202.94 Million 386.77 Million 19.51 Million
Operating Income 14.53 Million 12.38 Million 42.44 Million 179.03 Million 19.51 Million
Interest Expense 10 Million 7.57 Million 6.32 Million 1.18 Million 1 Million
Income Tax Expense 1.44 Million 1.13 Million 7.21 Million 35.44 Million 3.57 Million
Earnings before Tax 7.87 Million 4.91 Million 35.94 Million 177.34 Million 18.02 Million
Net Income 6.43 Million 3.77 Million 28.72 Million 141.9 Million 14.45 Million
Earnings Per Share Basic 0.49 0.29 2.43 12.82 1.83
Earnings Per Share Diluted 0.49 0.29 2.34 11.80 1.76
Weighted Average Shares Outstanding 13.12 Million 12.97 Million 11.82 Million 11.07 Million 7.9 Million
Weighted Average Shares Outstanding (Diluted) 13 Million 13.01 Million 12.29 Million 12.02 Million 8.23 Million
Gross Margin 0.42 0.42 0.47 0.52 0.41
EBIT Margin 0.21 0.18 0.25 0.34 0.12
Profit Margin 0.04 0.02 0.11 0.25 0.09
EBITDA 36.54 Million 32.12 Million 62.3 Million 192.86 Million 24.85 Million
Earnings Before Tax Margin 0.08 0.07 0.17 0.31 0.12

Income Statement Charts